Health Canada, the nation’s health department, said that drug regulations were being amended based on new research into the therapeutic benefits of psychedelics. “There has been emerging scientific evidence supporting potential therapeutic uses for some restricted drugs, most notably psychedelic restricted drugs such as MDMA and psilocybin,” Health Canada noted in the Canada Gazette, an […]
Iowa Medical Marijuana Regulators Vote to Keep THC Cap, Add Autism | Kate Zawidzki On Friday, November 2, the board that oversees Iowa’s medical marijuana program voted unanimously against recommending legislators to remove the current 3% THC limit on products. Additionally, the board voted to recommend that the state add autism to the list of qualifying conditions, but rejected expanding […]
Michigan Regulators Expand Pool of Eligible Medical Marijuana Patients | NORML LANSING, MI — State regulators took action last week to expand the pool of patients eligible to receive medical cannabis. Officials expanded the pool of qualifying conditions under the state’s medical access law to include those patients diagnosed with: arthritis, autism, chronic pain, colitis, inflammatory bowel disease, obsessive compulsive […]
Pennsylvania Regulators Expand Medical Marijuana Program | NORML HARRISBURG, PA — Pennsylvania Health Secretary Rachel Levine has signed off on a series of recommendations expanding patients’ access to medical cannabis. The changes, previously recommended by the state’s medical marijuana advisory board, expand the pool of patients eligible to receive medical cannabis therapy to include those suffering from opioid dependency, neurodegenerative […]